60
Participants
Start Date
February 18, 2002
Primary Completion Date
May 19, 2006
Study Completion Date
May 19, 2006
Topotecan
After stem cells are collected, Topotecan 3.5 mg/m\^2 intravenously given over 30 minutes on Days 1 - 5.
Cyclophosphamide
After stem cells are collected, Cyclophosphamide 1 g/m\^2/day intravenously given over 2 hours on Days 1 - 3.
Melphalan
After stem cells are collected, Melphalan 70 mg/m\^2/day intravenously given on Days 4 and 5.
Peripheral Blood Stem Cells
On Day 7, some or all of the stem cells will be reinfused.
U.T. M.D. Anderson Cancer Center, Houston
Collaborators (1)
SmithKline Beecham
INDUSTRY
M.D. Anderson Cancer Center
OTHER